We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8M
AUM Growth
+$681K
(+3.1%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,939.41%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,409
New
162
Increased
850
Reduced
1,040
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$114M |
| 2 |
Cadence Design Systems
CDNS
|
+$112M |
| 3 |
Fortinet
FTNT
|
+$81.7M |
| 4 |
Cummins
CMI
|
+$68.3M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$93.3M |
| 2 |
Waters Corp
WAT
|
+$87.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$87M |
| 4 |
Automatic Data Processing
ADP
|
+$74.9M |
| 5 |
Amphenol
APH
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 13% |
| 3 | Financials | 12.4% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBTX
851
DELISTED
Veritex Holdings
VBTX
| $386 | ﹤0.01% |
14,915
| – | – |
|
852
Vornado Realty Trust
VNO
$7.51B
| $386 | ﹤0.01% |
6,032
-1,500
| -20% | -$101K |
|
853
Fresenius Medical Care
FMS
$13.3B
| $384 | ﹤0.01% |
9,812
+745
| +8% | +$29.5K |
|
854
AerCap
AER
$24.1B
| $382 | ﹤0.01% |
7,345
+6,834
| +1,337% | +$335K |
|
855
Chemours
CC
$2.57B
| $374 | ﹤0.01% |
15,661
-632
| -4% | -$18.6K |
|
856
Greif
GEF
$4.54B
| $373 | ﹤0.01% |
11,480
-173
| -1% | -$6.44K |
|
|
BPMP
857
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $370 | ﹤0.01% |
23,926
| – | – |
|
858
Silgan Holdings
SLGN
$4.91B
| $369 | ﹤0.01% |
12,089
+4,489
| +59% | +$134K |
|
859
EQT Corp
EQT
$32.8B
| $368 | ﹤0.01% |
23,365
+19,604
| +521% | +$376K |
|
860
Timken Company
TKR
$9.88B
| $366 | ﹤0.01% |
7,131
| – | – |
|
|
CLGX
861
DELISTED
Corelogic, Inc.
CLGX
| $366 | ﹤0.01% |
8,759
-1,514
| -15% | -$61.8K |
|
862
Royal Bank of Canada
RY
$290B
| $364 | ﹤0.01% |
4,600
-122
| -3% | -$9.53K |
|
863
ResMed
RMD
$29B
| $363 | ﹤0.01% |
2,982
-72
| -2% | -$7.98K |
|
864
UBS Group
UBS
$172B
| $363 | ﹤0.01% |
30,672
-1,420
| -4% | -$17.4K |
|
865
W.R. Berkley
WRB
$27.9B
| $362 | ﹤0.01% |
12,409
-9,009
| -42% | -$247K |
|
866
iShares Global 100 ETF
IOO
$8.73B
| $361 | ﹤0.01% |
7,427
+27
| +0.4% | +$1.31K |
|
867
A.O. Smith
AOS
$8.55B
| $359 | ﹤0.01% |
7,641
-1,370
| -15% | -$67.2K |
|
868
Keurig Dr Pepper
KDP
$40.5B
| $358 | ﹤0.01% |
12,418
+81
| +0.7% | +$2.31K |
|
869
Sprott Physical Gold
PHYS
$14.7B
| $355 | ﹤0.01% |
31,380
| – | – |
|
|
AV
870
DELISTED
Aviva Plc
AV
| $355 | ﹤0.01% |
33,520
+205
| +0.6% | +$2 |
|
871
Emergent Biosolutions
EBS
$384M
| $354 | ﹤0.01% |
7,346
-606,923
| -99% | -$29.1M |
|
872
J&J Snack Foods
JJSF
$1.44B
| $353 | ﹤0.01% |
2,194
| – | – |
|
873
Invesco Biotechnology & Genome ETF
PBE
$286M
| $351 | ﹤0.01% |
6,579
| – | – |
|
|
BF
874
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $351 | ﹤0.01% |
19,340
+252
| +1% | +$5 |
|
875
Brown-Forman Class A
BF.A
$12.3B
| $346 | ﹤0.01% |
6,298
| – | – |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2019 Portfolio in Review
As of Q2 2019, Glenmede Trust held 3,409 positions worth $22.8M, up 3.1% from $22.1M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust withdrew a net $442M in Q2 2019, closing 145 positions and reducing 1,040 holdings. Its most notable exit was Sinclair Inc, an estimated $23.5K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Dow Inc worth $29.7K.
- Glenmede Trust's largest Q2 2019 buy was Dow Inc: 602,067 shares worth $29.7K.
- Glenmede Trust added most to Electronic Arts in Q2 2019, an estimated $114M increase.
- Glenmede Trust's biggest Q2 2019 reduction was Cognizant, cutting an estimated $93.3M.
- Glenmede Trust fully exited Sinclair Inc in Q2 2019, selling an estimated $23.5K.
- Glenmede Trust's ten largest holdings make up 14% of its $22.8M portfolio in Q2 2019.
- Glenmede Trust opened 162 new positions and closed 145 in Q2 2019.
- Glenmede Trust's portfolio value rose 3.1% quarter-over-quarter to $22.8M.
Based on Glenmede Trust's 13F filing for Q2 2019, filed 13 Aug 2019.